2023 International Congress Archives - Page 81 of 186

Sacral Mass Lesion Mimicking Atypical Foot Dystonia In Parkinsonian Patient

B. Barton (CHICAGO, USA)
SAFE-DBS – A monocentric, randomised, blind evaluation of safinamide in the perioperative period in Parkinsonian patients with deep brain stimulation

E. Gülke, M. Höfs, H. Pinnschmidt, A. Gulberti, C. Moll, U. Hidding, C. Buhmann, M. Heise, W. Hamel, M. Pötter-Nerger (Hamburg, Germany)
Safety and efficacy of focused ultrasound thalamotomy in essential tremor: a real scenario within the public health system.

D. Vilas, M. Tardáguila, L. Ispierto, J. Muñoz, M. Gea, A. González, R. álvarez (badalona, Spain)
Safety and efficacy of P2B001 (low dose combination of extended-release pramipexole and rasagiline) in patients with early Parkinson’s disease: Subgroup analyses from a randomized, controlled trial

D. Falconer, P. Litman, H. Friedman, S. Oren, C. Fitter-Attas (Alexandria, USA)
Safety and performance of DBS primary cell IPG replacement: An interim report from the ADROIT study

S. Groppa, J. Muñoz, K. Ashkan, A. Gharabaghi, T. Tomlinson, M. Frassica, M. Navas Garcia (Mainz, Germany)
Safety and pharmacokinetics of anti-inflammatory NE3107 treatment in carbidopa/levodopa-treated patients with Parkinson’s disease: A phase 2a, double-blind, placebo-controlled study

J. Aldred, R. Rodriguez, E. Rivera-Rivera, S. Isaacson, R. Kumar, A. Ellenbogen, C. Ahlem, C. Reading, J. Palumbo, N. Osman, A. Lang (Spokane, USA)
Safety assessment of pimavanserin in Parkinson’s disease psychosis patients: Evidence from a systematic review and meta-analysis of randomized controlled trials

G. Bano, A. Sharma (New Delhi, India)
Safety in Levodopa/carbidopa Intestinal Gel (LCGI) titration in the Intensive Care Unit (ICU) setting for Parkinson’s Disease (PD) patient with severe dysphagia

N. Lopez Ariztegui, G. Tabar Comellas, MI. Morales Casado, D. Rivero Rodriguez, M. Ennazeh, P. Leal Sanz (Toledo, Spain)
Safety of foslevodopa/foscarbidopa during optimization and maintenance treatment: Post hoc analysis of a phase 3, single-arm trial

D. Kern, S. Isaacson, S. Dhanani, J. Aldred, B. Bergmans, D. Santos-Garcia, T. Oeda, F. Gandor, P. Kukreja, L. Bergmann, R. Gupta, S. Talapala, A. Spiegel, T. Kimber (Aurora, USA)
Safety profile of pimavanserin therapy in elderly patients with neurodegenerative disease-related neuropsychiatric symptoms: a Phase 3b study

G. Alva, W. Cubala, A. Berrio, V. Abler, S. Pathak (Costa Mesa, USA)
Safinamide in Parkinson´s Disease. A retrospective study

M. Carmona-Abellan, M. Erburu, A. Cabrera, C. Garcia-Monco, K. Berganzo, B. Huete (Bilbao, Spain)
Salivary α-synuclein in Parkinson’s disease – a pilot study

M. Kaiserova, D. Hrabos, M. Levkova, M. Kavalkova, R. Kopacik, K. Mensikova, P. Kanovsky (Olomouc, Czech Republic)
SARS-CoV-2 infection exacerbates the cellular pathology in Parkinson’s disease progression

HN. Choi, BN. Lee, YH. Che, MG. Ko, HM. Seong, MG. Jo, KS. Lyoo, YJ. Kim, SP. Yun (Jin-Ju, Republic of Korea)
Screening and Treatment of Depression in Parkinson’s Disease Within Movement Disorders Centers

C. Marras, D. Weintraub, J. Beck, A. Naito, Z. Meyer, N. Dahodwala, T. Davis, K. Mills, J. Miyasaki, S. Mantri, M. Neault, A. Brown, A. Allen, E. Nelson, H. Liu (Toronto, Canada)
Screening risk of falls in Parkinson’s disease population living in underserved areas

T. Capato, J. Miranda, F. Santos, R. Cury, E. Barbosa (São Paulo, Brazil)
Selegiline drives autophagic secretion of α-synuclein

Y. Nakamura, S. Arawaka (Takatsuki, Japan)
Selenium mitigates ferroptosis-mediated dopaminergic cell death by regulating the Nrf2/GPX4 pathway: Implication for Parkinson’s disease

YJ. Jung, H. Choi, E. Oh (Daejeon, Republic of Korea)
self-compassion, trait worry and sleep in parkinson’s disease (PD) patients

M. Cusnir, S. Diaconu, E. Ungureanu, B. Ciopleiasb, R. Zosin, I. Murasan, C. Falup-Pecurariu (Brasov, Romania)
Self-perception of symptoms lateralization and association with symptoms severity in Parkinson’s disease.

V. Silva Costa, T. Figo Rocha, M. Oliveira Menacho, T. Silva Brito, A. Lepesteur Gianlorenço (São Carlos, Brazil)
Self-report vs. informant-report of problematic behaviors using the Huntington’s Disease-Behavioral Questionnaire

S. Hughes, E. Churchill, G. Parkin, B. Culbert, A. Smirnova, A. Hall, P. Gilbert, J. Corey-Bloom (San Diego, USA)
Sensitivity, consistency and test-retest reliability of home-based freezing of gait-provoking tests in people with Parkinson’s disease

D. Zoetewei, P. Ginis, M. Gilat, T. Herman, M. Brozgol, P. Thumm, J. Hausdorff, A. Nieuwboer, N. D'Cruz (Leuven, Belgium)
Sensor-based digital measurement of gait and wrist pronation-supination in clinically-defined classes of Parkinson’s disease progression identified by unsupervised clustering

D. Rodriguez Duque, J. Edgerton, L. Zhu, C. Kanzler, C. de Moor, S. Belachew, T. Dam, T. Liu, C. Shen, M. Yang, F. Nahab (Cambridge, USA)
Serotonin Coma: An Antipodal emergency

K C. Chudasama, V J. Jhala (Rajkot, India)
Serum levels of IL-1β and interleukin 6 in Parkinson’s disease

S. Fezai, M. Ben Mahmoud, S. Fray, H. Jamoussi, N. Ben Ali, M. Fredj (Tunis, Tunisia)
Serum Metabolomics in Parkinson’s Disease: Correlations with Fecal Microbiome, Fecal Metabolomics and Clinical Status

TS. Toh, CW. Chong, MF. Loke, JW. Hor, LC. Lit, J. Bowman, SL. Song, CSJ. Teh, S-Y. Lim, AH. Tan (Kuala Lumpur, Malaysia)
Serum neurofilament light-chain concentrations in essential tremor: A case-control study

M. Salinas, V. Salinas, M. Mcgurn, N. Hernandez, E. Louis (Dallas, USA)
Serum Zinc Deficiency could be associated with dementia conversion in Parkinson’s disease

W. Jang (Gangneung, Republic of Korea)
Severe movement disorder initially suspected of being conversion – key insights from the psychiatrist

L. Jaffe (Honolulu, USA)
Severe parkinsonism late-onset in Wilson’s disease without typical basal ganglia involvement

J. Li, K-F. Li, J. Ge, H-Z. Chen, W-M. Yang (Hefei, China)
Severe tacrolimus-induced parkinsonism after kidney transplantation

N. Riemersma, D. Kremer, R. Prak, F. Huser, M. Vander Stouwe, C. Vroomen, S. Bakker (Groningen, Netherlands)
Sex differences for clinicopathological correlations in people with Lewy body pathology

E. Bayram, D. Coughlin, I. Litvan (La Jolla, USA)
Sex differences for off episodes in Parkinson’s disease

A. Ratnavel, C. Jiang, A. Liu, K. Wang, A. Tsai, K. Wyman-Chick, E. Bayram (La Jolla, USA)
Sex differences in motor and non-motor symptoms in Parkinson’s disease in a diverse East London population

Z. Markovic-Obiago, E. Camboe, A. Zirra, T. Haque, K. Dey, A. Ben-Joseph, D. Gallagher, C. Budu, C. Simonet, A. Noyce (London, United Kingdom)
Sex differences in motor response to levodopa in early Parkinson’s disease

M. Gevertzman, A. Hooyman, J. Longhurst, M. Landers (Las Vegas, USA)
Sex Is Not a Major Determinant of Pallidus Internus Deep Brain Stimulation Outcome in Dystonia

R. Telese, L. Romito, N. Golfrè Andreasi, G. Zorzi, A. Elia, S. Rinaldo, G. Devigili, R. Cilia, G. Messina, V. Levi, A. Franzini, R. Eleopra (Milan, Italy)
Sex-Specific Association Between Plasma Vitamin D and Parkinson’s Disease: A Mendelian Randomization Study

T. Antar, H. Iwaki (Bethesda, USA)
Sex-specific speech correlates of dysphagia in Parkinson’s disease

JH. Ahn, D. Shin, MK. Suh, YE. Huh, J. Youn, JW. Cho, JS. Lee (Seoul, Republic of Korea)
Sexual health and sleep quality in women living with Parkinson’s disease: are we neglecting that?

KCN. Nobrega, TSM. Martins, GFS. Santos, MEP. Piemonte (Sao Paulo, Brazil)
Short and long-term effects of deep brain stimulation on cognition in Parkinson’s disease

S. Fjeldhøj, B. Thomsen, P. Pedersen, M. Karlsborg, O. Bergdal, A. Clausen, S. Jensen, B. Jespersen, A. Løkkegaard (Copenhagen, Denmark)
Short-term effect of continuous positive airway pressure in MSA patients with sleep disordered breathing

G. Lazzeri, M. Houot, M. Patout, F. Cormier, M. Vidailhet, JC. Corvol, I. Arnulf, D. Grabli, P. Dodet (Milan, Italy)
Short-term, intermittent exercise program improved the balance and gait in patients with Parkinson’s disease

YC. Chein, JC. Hsu, KH. Chen, HY. Chen, CF. Lo, WE. Lee (Hsinchu City, Taiwan)
Signs of Respiratory Dysfunction across Parkinson’s Disease Spectrum

J. Janssen Daalen, P. Ainslie, H. van Hees, M. Meinders, D. Thijsse, B. Bloem (Nijmegen, Netherlands)
Single-center experience of deep brain stimulation (DBS) surgery in Malaysia

AM. Dy Closas, AH. Tan, JL. Lim, YW. Tay, A. Ahmad-Annuar, K. Lohmann, C. Klein, CY. Cham, KA. Muthusamy, SY. Lim (Kuala Lumpur, Malaysia)
SLC1A7 mutation is a cause of the autosomal dominant form of Parkinson’s disease

A. Kishore, M. Marc Sturm, F. Raimondi, P. Lichtner, A. Sreelatha, N. Casadei, C. Blauwendraat, G. Sarma, R. Kruger, A. Zimprich, A. Singleton, T. Gasser, O. Riess, M. Sharma (Kochi, India)
Sleep disorders and their relationship to non-motor symptoms in Mexican Parkinson’s disease patients

D. Aguila-Godinez, A. Herrera Ruiz, E. Santiago, L. Lira Juarez, MA. Medrano Delgado, M. Ruiz Mafud, A. Hernandez-Medrano, A. Regalado Mustafa, G. Cerda Hernandez, M. Rodriguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Dominguez Garcia, D. Romero-Teran, K. Talvera-Lagunas, M. Medina Perez (Mexico City, Mexico)
Sleep disorders in Parkinson’s disease patients. A case-control study.

L. Rotaru, M. Cebuc, A. Lupușor, O. Grosu, S. Odobescu, O. Gavriliuc, I. Moldovanu (Chisinau, Republic of Moldova)
Sleep hygiene practice in patients with Parkinson’s disease

JY. Yun, CY. Lee, D. Kim, JH. Kim (Seoul, Republic of Korea)
Sleep quality in GBA, LRRK2 and idiopathic Parkinson disease

A. Yoo, R. Ortega, D. Raymond, B. Plitnick, M. Markgraf, J. Liang, M. Rawal, A. Wise, M. Pullman, K. Leaver, V. Katsnelson, J. Miravite, V. Shanker, M. Swan, M. Figueiro, S. Bressman, R. Saunders-Pullman (New York, USA)
Sleep seasonality in alpha-synucleinopathies: a comparative study with non-neurological sleep disorder patients

P. Bugalho, B. Meira, M. Magriço (Lisboa, Portugal)
Sleep-Wake Dependent Modulation in Pallidal Beta and High-Frequency Oscillations in Parkinson’s Disease

A. Verma, S. Acosta-Lenis, J. Aman, J. Wang, A. Pearson, M. Hill, R. Patriat, S. Cooper, M. Park, N. Harel, M. Howell, C. Mackinnon, J. Vitek, L. Johnson (Minneapolis, USA)
Slow progressive neurocognitive impairment with Parkinsonism: A rare, adult-onset Neuronal Intranuclear Inclusion disease (NIID) case report

AS. Mawardi, AA. Ab Ghapar, NH. Rahim, J. Joseph (Kuala Lumpur, Malaysia)
SLP-2 modulated expression rescues mitochondrial function in alpha-synuclein neuropathology models

M. Castelo, G. Gentile, A. Zanon, A. Lavdas, C. Bolduc, M. Picon, S. Laouafa, J. Soliz, M. Lévesque, I. Pichler (Bolzano, Italy)
Small Molecule Inhibitors for Precise Inhibition of α-Synuclein Oligomer Generation in Parkinson’s Disease (PD)

A. Cridland, S. Ball, X. Teng, M. Castellana Cruz, K. Pisani, J. Olano Bringas, P. Villegas, I. Kitchen-Smith, X. Yang, B. Mannini, N. Bengoa-Vergniory, S. Brewerton, B. Li, R. Sivasankaran, J. Popovici-Muller, A. Plowright, J. Thomson, J. Habchi (Cambridge, United Kingdom)
Smartphone App-Based Stroop Test as a surrogate for impaired self-awareness in Parkinson’s disease.

F. Thieken, S. Wattendorf, P. Korn, M. Kontz, O. Ataiy, P. Fischer, MO. Ashraf, V. Gross, D. Pedrosa, K. Sohrabi, L. Timmermann (Marburg, Germany)
Social and gender inequity on overall survival and access to deep brain stimulation in Parkinson disease patients in Colombia

C. Pantoja-Ruiz, D. Rosselli (Bogota, Colombia)
Social cognition in cervical dystonia: an fMRI study

S. Rafee, D. Kelly, C. Fearon, M. Hutchinson, R. Reilly (Dublin, Ireland)
Space-occupying lesion presenting with hand dystonia

S. Lopes, M. Santos, R. Pereira, M. Cambango, L. Oliveira, S. Varanda (Braga, Portugal)
Specific ethnicity could have different risk factors for Parkinson’s disease: a descriptive study

S. Marisdina, S. Handayani, Y. Diansari, M. Odiesta (Palembang, Indonesia)
Specific Parkinson’s disease phenotype in patients with long term PTSP

I. šarac, H. šarac, N. Henigsberg, F. Borovečki, Z. Krešić, I. Ivek, T. Sukobljević (Zagreb, Croatia)
Spectrogram helps to differentiate functional tremor from organic

K. Evdokimov, E. Fedotova, A. Broutian, S. Illarioshkin (Moscow, Russian Federation)
Spectrum of Hereditary Spastic Paraparesis (HSP): A study from India

AK. Srivastava, A. Agarwal, F. Mohammad, D. Mr, A. Sonakar, R. Rajan, P. Sharma, S. Zahra, T. de, M. Fatima, S. Bari (New Delhi, India)
Spectrum of hyperkinetic movement disorders in a Tunisian Cohort: an observational study

S. Laroussi, S. Daoud, N. Bouattour, S. Sakka, K. Moalla, M. Damak, N. Farhat, C. Mhiri (Sfax, Tunisia)
Speech difficulties and dopaminergic neurodegeneration in Parkinson’s Disease

S. Polychronis, B. Ribba, G. Nasios, E. Dardiotis, G. Pagano (Ioannina, Greece)
Speech, gait and vestibular instrumental assessment in CANVAS: a case series.

G. Di Rauso, F. Cavallieri, V. Fioravanti, E. Monfrini, A. Gessani, I. Campanini, A. Merlo, A. Castellucci, D. Ronchi, M. Napoli, R. Pascarella, S. Grisanti, R. Sabadini, C. Zini, A. Di Fonzo, F. Valzania (Modena, Italy)
SpeechATAX: A rater blinded randomized controlled trial of intensive home-based biofeedback therapy for dysarthria in progressive ataxia

A. Vogel, L. Graf, H. Reece, M. Magee, V. Soo, S. Braat, E. Petit, S. Borel, A. Durr, R. Roxburgh, M. Synofzik (Melbourne, Australia)
Spinal cord stimulation for gait in Parkinsons disease in subthreshold settings

R. Carra, J. Menezes, K. Duarte, M. Teixeira, E. Barbosa, R. Cury (Sao Paulo, Brazil)
Spinocerebellar Ataxia Autosomal Recessive Type 10 Misdiagnosed as a Multiple System Atrophy Type C: a Case Report.

S. Gallo, M. Fabbri, F. Ory-Magne, O. Rascol (Toulouse, France)
Spinocerebellar ataxia type 28 presenting as spastic paraparesis

R. Hoe, S. Neo, L. Tan (Singapore, Singapore)
Spiral drawing features are similar between essential tremor and essential tremor plus

R. Anandapadmanabhan, A. Vishnoi, A. Latorre, N. Thirugnanasambandam, A. Dipani, D. Biswas, A. Srivastava, K. Bhatia, R. Rajan (New Delhi, India)
Spiral Tunneling Technique for passing electrode lead for Deep Brain Stimulation(DBS) surgery in Parkinson’s disease(PD)

A. Uppar, D. Srinivas (BANGALORE, India)
Spontaneous intracranial hypotension presenting with progressive cerebellar ataxia and myelopathy

A. Cabral, A. Miranda, S. Casanova, F. Costa, M. Rodrigues, M. Branco (Gaia, Portugal)
Sport based approach in patients with Parkinson’s disease

G. Peker (CABA, Argentina)
Stability and predictability of motor symptom control in patients with advanced Parkinson’s disease (aPD) receiving continuous subcutaneous foslevodopa/foscarbidopa (LDP/CDP)

R. Pahwa, I. Malaty, M. Soileau, V. Fung, D. Santos Garcia, C. Carroll, T. Henriksen, A. Epstein, C. Yan, A. Alobaidi, A. Shewale, A. Spiegel, M. Facheris, M. Shah, P. Kukreja, J. Zamudio, K. Chaudhuri (Kansas City, USA)
Stability of basal ganglia beta band power distribution during continuous deep brain stimulation in Parkinson’s disease: analysis of sub-cohort from the ADAPT-PD trial

L. Hammer, E. Yilmaz, S. Little, H. Zahed, M. Volz, S. Ravi, S. Wang, P. Starr, J. Ostrem (San Francisco, USA)
Stability of beta oscillations during aDBS in Parkinson’s disease: a methodology for reliable assessment

S. Marceglia, A. Caruso, M. Prenassi, M. Arlotti, T. Bocci, L. Borellini, S. Pastore (Trieste, Italy)
Staged and simultaneous bilateral MRI-guided focused ultrasound treatment of essential tremor

R. Galimova, D. Nabiullina, S. Illarioshkin, I. Buzaev, S. Safin, G. Akhmadeeva (Ufa, Russian Federation)
Stepwise Dual-Target MR-guided Focused Ultrasound in A Patient with Advanced Parkinson’s Disease

CH. Tsai, MK. Lu, JC. Chen, CM. Chen (Taichung, Taiwan)
Stiff person syndrome vs functional neurological disorder: two patients with hyperkinetic movement disorder

J. Garcia, S. Mireles, Y. Martinez, A. Alcocer (Mexico, Mexico)
Stiff-person syndrome associated with anti-Yo1 antibodies: a case report

E. Chekanova, I. Luneva, A. Kozlova, O. Smetanina, M. Zakharova (Moscow, Russian Federation)
Stiff-Person Syndrome: Diagnosis and Experimental Models

D. Labunskiy, S. Kiryukhina, N. Kolmykova, N. Kurgaev (Saransk, Russian Federation)
Stop signal reaction time: A promising Diagnostic marker for Functional Cervical Dystonia

SB. Banerjee, SC. Choudhury, AR. Roy, PK. Jakati, PB. Basu, SM. Mukherjee, JG. Ganguly, NS. Singh, MRB. Baker, SNB. Baker, HK. Kumar (KOLKATA, India)
STRAT-PARK: a biomarker and stratification initiative for Parkinson’s disease

K. Stige, S. Kverneng, S. Sharma, GO. Skeie, E. Sheard, M. Søgnen, S. Af Geijerstam, T. Vetås, C. Dölle, F. Dick, A. Wahlvåg, E. Berntsen, F. Riemer, P. Goa, K. Haugarvoll, S. Buch, D. Reese, D. Babiker, Y. Mahdi, T. Wade, G. Miranda, J. Ganguly, Y. Tamilselvam, J. Chai, S. Bansal, D. Aur, M. Haacke, M. Jog, C. Tzoulis (Trondheim, Norway)
Strategic decision-making in Parkinson’s disease with fatigue

C. Pauletti, D. Mannarelli, F. Milano, A. Maffucci, A. Petritis, F. Fattapposta (Rome, Italy)
Striatal neurodegeneration in female carriers of the TAF1 Mutation Causing X-linked Dystonia-Parkinsonism

H. Hanssen, J. Dy, J. Tantianpact, M. Heldmann, H. Manalo, C. Klein, A. Westenberger, J. Oropilla, C. Diesta, N. Brüggemann (Lübeck, Germany)
Structural analysis of the basal ganglia using ex vivo 7T MRI can differentiate frontotemporal lobar degeneration with TDP-43 vs tau accumulation.

R. Williamson, P. Khandelwal, S. Das, G. Mizsei, K. Prabhakaran, R. Ittyerah, D. Wolk, J. Detre, P. Yushkevich, E. Lee, J. Gee, M. Grossman, C. Mcmillan, M. Tisdall, D. Irwin (Philadelphia, USA)
Structural MRI Analysis of Basal Ganglia volume and White Matter Tracts in Upper Limb Dystonia

DD. de Faria, JPQ. de Paiva, AJM. Paulo, VB. Borges, SM. Silva, HB. Ferraz, PMC. Aguiar (São Paulo, Brazil)
Structural MRI and tremor analysis in the differential diagnosis of rest tremor

F. Aracri, M. Bianco, C. Calomino, M. de Maria, B. Vescio, J. Buonocore, A. Sarica, A. Quattrone (Catanzaro, Italy)
Studies on mitochondrial dysfunction in the peripheral blood mononuclear cells in an ethnic Indian population of SCA 12 patients

S. Ansari, J. Rungta, R. Pal, S. Choudhury, R. Banerjee, S. Dey, H. Kumar (Kolkata, India)
Study protocol for the iMarkHD study in individuals with Huntington’s disease

D. van Wamelen, T. Wood, M. Veronese, C. Ginestet, N. Martin, O. Makos, J. Badenoch, M. Hartmann, A. Rangel Cristales, E. Rabiner, R. Gunn, S. Tabrizi, A. Wood, S. Williams (London, United Kingdom)
Sub-cellular alterations in MPTP-induced in-vivo and in-vitro systems and Non-MPTP human Parkinsonian skin biopsies: Verifying the sequelae of differential toxicity

P. Alladi, B. Bhaduri, S. Rashmi, I. Datta, P. Pal, D. Srinivas, R. Yadav (Bangalore, India)
Subacute Encephalopathy with Seizures in Alcohol Consumers (SESA) presenting as Focal Dyskinesias and Myoclonus

D. Desai, S. Desai (Anand, India)
Subacute parkinsonism associated with Zic4 antibodies: a case report

V. Mendes Ferreira, M. Magriço, D. Krupka, B. Meira (Lisboa, Portugal)
Subanesthetic infusion of ketamine produces long-term reduction in levodopa-induced dyskinesia and depression in individuals with Parkinson’s Disease

T. Falk, S. Richards, M. Bartlett, A. Lind, C. Hsu, S. Sherman (Tucson, USA)
Subject-specific investigation of pathways underlying therapeutic outcomes of deep brain stimulation for Essential Tremor

R. Butler, M. Blumenfeld, A. Brinda, M. Bryants, D. Sullivan, S. Pandey, T. Palnitkar, R. Patriat, J. Vitek, L. Schrock, K. Gagesch, K. Domingo, T. Orcutt, N. Harel, J. Matsumoto, S. Cooper, M. Johnson (Minneapolis, USA)
Subjective assessment of parkinson’s disease in relation to changes in brain microstructure

H. Kujirai, T. Ogawa, K. Kamagata, T. Hatano, W. Uchida, H. Amano, S. Aoki, N. Hattori (Tokyo, Japan)
Subjective cognitive complaints in participants of the Healthy Brain Ageing (HeBA) study

S. Jónsdóttir, C. Pauly, O. Tsurkalenko, E. Thiry, AM. Hanff, T. Marques, C. Horlings, A. Garrido, C. Vega, S. Schade, P. Mahlknecht, C. Gomes, S. Ghosh, K. Rege, R. Rawal, D. Mcintyre, K. Seppi, M. Martí, C. Trenkwalder, E. Tolosa, W. Poewe, V. Satagopam, R. Krüger, B. Mollenhauer (Heisdorf, Luxembourg)
Subjective cognitive complaints in patients with progressive supranuclear palsy and corticobasal syndrome

JS. Lee, JH. Ahn, J. Youn, JW. Cho (Seoul, Republic of Korea)
Subjective cognitive decline and Frailty in an Asian cohort of patients with Parkinson’s Disease

P. Venugopalan Menon, K. Gai Fui, E. Elda Kamaruddin, L. Sun, CH. Tan, P. Chong, S. Kumar Seetharaman (Singapore, Singapore)
Subjective cognitive decline as predictor of objective cognitive decline in Parkinson’s patients

T. Blum, H. Wurp, S. Wolfsgruber, M. Wagner, L. Consortium, R. Dodel (Essen, Germany)
Substantia Nigra blood-brain barrier opening in Parkinson´s disease: PET (18F-Choline) evidence of parenchymal penetration

C. Gasca-Salas, P. Pineda-Pardo, M. Del álamo, T. Jiménez, C. Trompeta, L. García-Cañamaque, B. Fernández-Rodríguez, M. Matarazzo, I. Plaza Delasheras, E. Natera, R. Martínez-Fernández, S. Ruiz Deaguiar, J. Blesa, J. Obeso (Móstoles, Spain)
Subthalamic Nucleus Deep Brain Stimulation in GBA-associated Parkinson Disease: Cognitive and motor follow-up of two clinical cases

I. Carvalho, D. Damas, I. Cunha, S. Caldeira, P. Monteiro, R. Pereira, F. Moreira (Coimbra, Portugal)
Subthalamic nucleus deep brain stimulation in the beta range modulates cortical beta oscillations in Parkinson’s disease patients

L. Werner, A. Schnitzler, J. Hirschmann (Düsseldorf, Germany)
Subthalamic stimulation reshapes the reliable inherent brain state in Parkinson’s disease

C. Chu, N. He, Z. Zeng, Y. Zhang, X. Wang, Z. Zhang, J. Wang, Y. Wang, Z. Jiang, Y. Lu, B. Sun, F. Yan, D. Li, C. Zhang, C. Liu (Tianjin, China)
Subtyping Parkinson’s disease: Quality of life changes after subthalamic stimulation depend on nonmotor and motor symptoms

L. Braun, S. Jost, P. Loehrer, A. Sauerbier, K. Ashkan, A. Rizos, M. Santos Ghilardi, A. Gronostay, J. Evans, M. Silverdale, R. Cury, E. Fonoff, G. Fink, A. Antonini, C. Nimsky, K. Chaudhuri, L. Timmermann, V. Visser-Vandewalle, P. Martinez-Martin, H. Dafsari (Cologne, Germany)
Success of MRI-guided focused ultrasound thalamotomy after failure of Gamma Knife radiosurgery for essential tremor

V. Fleury, DR. Romascano, OL. Lorton, CT. Tuleasca, SCC. Catalano Chiuve, RS. Salomir, ML. Levivier, SM. Momjian, PRB. Burkhard (GENEVE 14, Switzerland)
Suicidal ideation and suicide risk in Parkinson’s disease

J. Lam, X. Tang, D. Meng, J. Zhu, P. Uzelman, F. Pio, S. Appel-Cresswell (Vancouver, Canada)
Supine hypertension is longitudinally associated with cognitive decline in Parkinson disease independent of orthostatic hypotension

C. Miller-Patterson, J. Hsu, M. Barrett, L. Cloud, T. Chelimsky (Richmond, USA)
Supra-ON state freezing of gait: The unpredictable response to levodopa in Parkinson´s Disease

M. Magriço, V. Ferreira, B. Meira, R. Barbosa (Lisboa, Portugal)
Sympathetic tone abnormalities in subjects at risk for Parkinson’s Disease without evidence of nigrostriatal neurodegeneration: a multimodal biomarker study

M. Gregorio, H. Maghzi, G. Obialisi, E. Hogg, C. Malatt, E. Tan, H. Pomeroy, R. Artal, M. Shehata, B. Renner, P. Sati, G. Pagano, M. Tagliati (Los Angeles, USA)
Synaptic density and α-synuclein oligomers in skin biopsies: differences between idiopathic and GBA-linked Parkinson’s disease

E. Contaldi, S. Mazzetti, M. Basellini, V. Ferri, E. Cereda, I. Isaias, G. Pezzoli, G. Cappelletti (Milan, Italy)
SYNCHRONIZE: Real-world retrospective safety analysis in patients treated with onabotulinumtoxinA for more than one therapeutic indication

A. Patel, G. Forde, K. Martinez, A. Mayadev, B. Brucker, K. Becker Ifantides, R. Singh, M. Nelson, I. Yushmanova, S. Battucci, C. Rhyne (Overland Park, USA)
Systemic and intracellular iron starvation response in Friedreich´s Ataxia

E. Indelicato, M. Amprosi, A. Eigentler, W. Nachbauer, D. Haschka, M. Grander, B. Henninger, C. Kremser, G. Weiss, S. Boesch (Innsbruck, Austria)